Dexmedetomidine in Sonographic Guided Erector Spinae Plane Block

Phase 3RecruitingNCT06899841

Assiut University90 enrolled

Overview

to investigate the postoperative analgesic effect of dexmedetomidine addition with different doses as an adjuvant to bupivacaine to Erector spinae plane block after renal surgeries.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

TRIPLE

Enrollment

Conditions

Pain Management

Interventions

DexmedetomidineDRUG

different doses of dexmedetomidine added to bupivacaine in erector spinae plane block

Eligibility

Sex: ALLMin age: 18 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age between 18 and 70 years. * Both sexes, males and females. * Patients with the American Society of Anesthesiologists (ASA) physical status I/II. * Body mass index (BMI) of 18-35 kg/m2 * Patients scheduled for elective Renal or Percutaneous Nephrolithotomy. Exclusion Criteria: * Patients under 18 years. * Patient refusal of nerve block. * Infection at the site of injection. * Coagulopathy. * Allergy to used medications. * Psychiatric disorder or chronic pain syndromes. * Chronic opioid use or substance abuse. * Quadriplegic patients.

Locations (1)

Assiut University Hospitals

Asyut, Assiut Governorate, Egypt

RECRUITING

Outcomes

Primary Outcomes

postoperative analgesic duration

postoperative analgesic duration with each dose

Time frame: 24 hours

Secondary Outcomes

Pain score

severity of pain using visual analogue pain score

Time frame: 24 hours

side effects

as hemodynamic effect as (hypotension, bradycardia), nausea and vomiting.

Time frame: 24 hours

dynamic pain score

Dynamic visual analogue pain score (pain with cough, deep breath, and movement)

Time frame: 24 hours

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.